ACW actinogen medical limited

News: ACW Actinogen Medical Says Reassessed Priorities & Expenditures Resulting In Strategic...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    May 4 (Reuters) - Actinogen Medical Ltd (ACW) :

    • ACTINOGEN MEDICAL LTD - CONDUCTED A REASSESSMENT OF ITS PRIORITIES AND PLANNED EXPENDITURES, RESULTING IN STRATEGIC ADJUSTMENTS
    • ACTINOGEN MEDICAL - STRATEGIC ADJUSTMENTS TO PRIORITIZE ALZHEIMER'S DISEASE & MAJOR DEPRESSIVE DISORDER PROGRAMS FOR XANAMEM
    • ACTINOGEN MEDICAL - SUSPEND CLINICAL TRIAL OPERATIONS FOR ITS XANAFX FRAGILE X SYNDROME TRIAL & REALLOCATE THOSE RESOURCES TO AD AND MDD
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $85.73M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 533350 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 797223 3
View Market Depth
Last trade - 09.42am 15/09/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.